1 - 25 of
34
results
for author:"Landt O."
in Literature Citations
| Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. Halangk J., Sarrazin C., Neumann K., Puhl G., Mueller T., Teuber G., Klinker H., Hinrichsen H., Buggisch P., Landt O. et al. J. Hepatol. 49:339-345(2008) · Mapped (2) |
| The SPINK1 N34S variant is associated with acute pancreatitis. O'Reilly D.A., Witt H., Rahman S.H., Schulz H.U., Sargen K., Kage A., Cartmell M.T., Landt O., Larvin M., Demaine A.G. et al. Eur J Gastroenterol Hepatol 20:726-731(2008) · Mapped (1) |
| Rapid detection of the hOGG1 Ser326Cys polymorphism using LightCycler technology. Rihs H.P., Marczynski B., Rabstein S., Scherenberg M., Landt O., Bruning T. J. Toxicol. Environ. Health Part A 71:877-880(2008) · Mapped (5) |
| MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians. Bittenbring J., Parisot F., Wabo A., Mueller M., Kerschenmeyer L., Kreuz M., Truemper L., Landt O., Menzel A., Pfreundschuh M. et al. BMC Cancer 8:116-116(2008) · Mapped (57) |
| Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Elmaagacli A.H., Koldehoff M., Landt O., Beelen D.W. Bone Marrow Transplant. 41:821-826(2008) · Mapped (23) |
| No association of the CARD8 (TUCAN) c.30T>A (p.C10X) variant with Crohn's disease: a study in 3 independent European cohorts. Buning C., Schmidt H.H., Molnar T., Drenth J.P., Fiedler T., Gentz E., Todorov T., Baumgart D.C., Sturm A., Nagy F. et al. Inflamm. Bowel Dis. 14:332-337(2008) · Mapped (14) |
| Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Rosendahl J., Witt H., Szmola R., Bhatia E., Ozsvari B., Landt O., Schulz H.-U., Gress T.M., Pfuetzer R., Loehr M. et al. |
| Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. Buning C., Schmidt H.H., Molnar T., De Jong D.J., Fiedler T., Buhner S., Sturm A., Baumgart D.C., Nagy F., Lonovics J. et al. Aliment. Pharmacol. Ther. 26:1025-1033(2007) · Mapped (30) |
| Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Stutzmann F., Vatin V., Cauchi S., Morandi A., Jouret B., Landt O., Tounian P., Levy-Marchal C., Buzzetti R., Pinelli L. et al. Hum. Mol. Genet. 16:1837-1844(2007) · Mapped (1) |
| UGT1A7 polymorphisms in chronic pancreatitis: an example of genotyping pitfalls. te Morsche R.H., Drenth J.P., Truninger K., Schulz H.U., Kage A., Landt O., Verlaan M., Rosendahl J., Macek M. Jr., Jansen J.B. et al. Pharmacogenomics J. 8:34-41(2008) · Mapped (16) |
| Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia. Scholl S., Mugge L.O., Landt O., Loncarevic I.F., Kunert C., Clement J.H., Hoffken K. Leuk. Res. 31:1205-1211(2007) · Mapped (6) |
| The significance of C3435T point mutation of the MDR1 gene in endometrial cancer. Mrozikiewicz P.M., Seremak-Mrozikiewicz A., Semczuk A., Landt O., Breborowicz G.H., Drews K. Int. J. Gynecol. Cancer 17:728-731(2007) · Mapped (8) |
| Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer. Treiber M., Schulz H.U., Landt O., Drenth J.P., Castellani C., Real F.X., Akar N., Ammann R.W., Bargetzi M., Bhatia E. et al. J. Mol. Med. 84:1015-1022(2006) · Mapped (4) |
| A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Witt H., Sahin-Toth M., Landt O., Chen J.M., Kahne T., Drenth J.P., Kukor Z., Szepessy E., Halangk W., Dahm S. et al. Nat. Genet. 38:668-673(2006) · Mapped (7) |
| DLG5 variants in inflammatory bowel disease. Buning C., Geerdts L., Fiedler T., Gentz E., Pitre G., Reuter W., Luck W., Buhner S., Molnar T., Nagy F. et al. Am. J. Gastroenterol. 101:786-792(2006) · Mapped (9) |
| Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional study. Ahlenstiel G., Iwan A., Nattermann J., Bueren K., Rockstroh J.K., Brackmann H.H., Kupfer B., Landt O., Peled A., Sauerbruch T. et al. World J. Gastroenterol. 11:7631-7638(2005) · Mapped (3) |
| Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases. Verlaan M., Drenth J.P., Truninger K., Koudova M., Schulz H.U., Bargetzi M., Kunzli B., Friess H., Cerny M., Kage A. et al. J. Med. Genet. 42:e62-e62(2005) · Mapped (16) |
| Rapid detection of the SPINK5 polymorphism Glu420Lys by real-time PCR technology. Rihs H.P., Kowal A., Raulf-Heimsoth M., Degens P.O., Landt O., Bruning T. Clin. Chim. Acta 355:185-189(2005) · Mapped (6) |
| Genotyping of the PXR A11156C polymorphism with locked nucleic acid containing fluorogenic probes. Op den Buijsch R.A., de Vries J.E., Loots W.J., Landt O., Wijnen P.A., van Dieijen-Visser M.P., Bekers O. Pharmacogenomics J. 5:72-74(2005) · Mapped (5) |
| Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism. Hennig J., Reuter M., Netter P., Burk C., Landt O. Behav. Neurosci. 119:16-25(2005) · Mapped (15) |
| Rapid presumptive identification of Burkholderia pseudomallei with real-time PCR assays using fluorescent hybridization probes. Tomaso H., Pitt T.L., Landt O., Al Dahouk S., Scholz H.C., Reisinger E.C., Sprague L.D., Rathmann I., Neubauer H. Mol. Cell. Probes 19:9-20(2005) · UniProtKB (1) |
| Keratin 8 Y54H and G62C mutations are not associated with inflammatory bowel disease. Buning C., Halangk J., Dignass A., Ockenga J., Deindl P., Nickel R., Genschel J., Landt O., Lochs H., Schmidt H. et al. Dig Liver Dis 36:388-391(2004) · Mapped (5) |
| Keratin 8 Y54H and G62C mutations are not associated with liver disease. Halangk J., Berg T., Puhl G., Mueller T., Nickel R., Kage A., Landt O., Luck W., Wiedenmann B., Neuhaus P. et al. J. Med. Genet. 41:e92-e92(2004) · Mapped (4) |
| Polymorphic metabolic susceptibility genes and longevity: a study in octogonarians. Pesch B., Dusing R., Rabstein S., Harth V., Grentrup D., Bruning T., Landt O., Vetter H., Ko Y.D. Toxicol. Lett. 151:283-290(2004) · Mapped (19) |
| Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx. Aebersold D.M., Landt O., Berthou S., Gruber G., Beer K.T., Greiner R.H., Zimmer Y. Oncogene 22:8519-8523(2003) · Mapped (23) |
